PCPunnawat Chandrachamnong

Punnawat Chandrachamnong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Punnawat Chandrachamnong has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is age just a number? Causal modeling of recurrence risk in rectal cancer

    by Thanat Tantinam, Pawit Sutharat, Suwan Sanmee, Ekkarin Supatrakul, Jiraporn Khorana, Sunhawit Junrungsee, Kullawat Bhatanaprabhabhan, Boonchai Ngamsirimas, Nataphon Santrakul, Rangsima Thiengthiantham, et al.

    Purpose: Young-onset rectal cancer (YORC) is increasingly common and often presents with aggressive histological features; however, its effect on recurrence remains uncertain. This study aimed to estimate the causal effect of age at diagnosis on recurrence in patients with rectal cancer using advanced causal inference methods.Methods: This multicenter retrospective cohort study was conducted at 2 university hospitals in Thailand. Patients diagnosed with rectal adenocarcinoma between 2013 and 2022 who underwent curative-intent treatment were included. The primary exposure was age at diagnosis, categorized as YORC (<50 years) or late-onset rectal cancer (LORC; ≥50 years). Confounders were prespecified using a directed acyclic graph and addressed using a confounder composite score. Age was also modeled as a continuous variable using natural splines. The primary outcome was cancer recurrence.Results: Among 585 patients, 116 (19.8%) had YORC and 469 (80.2%) had LORC. Patients with YORC had fewer comorbidities but more unfavorable histological features than those with LORC. Overall, recurrence occurred in 40.2% of patients and most commonly involved distant metastasis. The estimated average causal effect of age on recurrence was −6.5% (95% confidence interval, −16.6% to 3.5%; P=0.202), indicating that younger age was not associated with an increased risk of recurrence, although a protective effect was not confirmed. Natural spline modeling indicated a nonlinear increase in recurrence hazard with advancing age.Conclusion: Younger age at diagnosis was not associated with worse recurrence outcomes despite adverse pathological features, and a potential protective association could not be excluded.

  • Correction to: Predictive Factors of Recurrence in Non-Operative Management of Right-Side Colonic Diverticulitis: Multicenter Retrospective Cohort Study

    by Khajohnsak Bhocksombud, Ekkarin Supatrakul, Kullawat Bhatanaprabhabhan, Boonchai Ngamsirimas, Nataphon Santrakul, Rangsima Thiengthiantham, Pawit Sutharat, Suwan Sanmee, Witcha Vipudhamorn, Punnawat Chandrachamnong

  • Correction to: Incidence of Stoma-Related Complications after Loop Colostomy and Loop Ileostomy: A Single-Center Retrospective Cohort Study

    by Abdullah Hamad, Kullawat Bhatanaprabhabhan, Boonchai Ngamsirimas, Wanida Ratirotjanakul, Suchada Usaviroj, Punnawat Chandrachamnong

  • Open Access

    From regression to machine learning: improving prediction of rectal cancer recurrence

    by Thanat Tantinam, Ekkarin Supatrakul, Pawit Sutharat, Suwan Sanmee, Kullawat Bhatanaprabhabhan, Boonchai Ngamsirimas, Nataphon Santrakul, Rangsima Thiengthiantham, Punnawat Chandrachamnong, Suradet Buakhrun, et al.

    Recurrence after curative-intent treatment of rectal cancer remains a major clinical challenge. Conventional regression models may not adequately capture complex clinical interactions, whereas machine learning algorithms may improve predictive accuracy. This study compared regression-based and machine learning models for predicting recurrence using routinely collected clinical data. A retrospective cohort of 581 patients with rectal adenocarcinoma treated between 2013 and 2022 at 2 university hospitals in Thailand was analyzed. Seventeen demographic, pathological, and treatment-related features were used to develop logistic regression (LR), random forest (RF), support vector machine, extreme gradient boosting (XGBoost), and light gradient boosting machine (LightGBM) models. Data were split using stratified train-test sampling (80:20). Fivefold cross-validation, calibration, and decision curve analyses were performed. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), average precision (AP), F1 score, sensitivity, specificity, and feature importance. All models demonstrated moderate discriminative performance. AUC values ranged from 0.626 (LightGBM) to 0.662 (XGBoost), while AP scores ranged from 0.483 (LightGBM) to 0.584 (RF). LR achieved perfect sensitivity (1.000) at the F1-optimized threshold, RF provided the strongest balance between precision and recall, and XGBoost achieved the highest AUC. Key predictors included carcinoembryonic antigen level, nodal status, surgical margin status, tumor grade, lymphovascular invasion, and the number of lymph nodes retrieved. Machine learning models modestly outperformed regression-based approaches, although their clinical value lies primarily in tailoring model strengths to specific priorities. Selecting LR, RF, or XGBoost according to objectives such as maximizing sensitivity, achieving balanced precision-recall, or enabling risk stratification may enhance recurrence surveillance in rectal cancer.

  • Open Access

    Propensity score–matched comparative study of radiofrequency ablation (with the Rafaelo device) versus hemorrhoidectomy for the treatment of grades II–III internal hemorrhoids

    by Thanat Tantinam, Pawit Sutharat, Suwan Sanmee, Ekkarin Supatrakul, Kullawat Bhatanaprabhabhan, Boonchai Ngamsirimas, Nataphon Santrakul, Rangsima Thiengthiantham, Punnawat Chandrachamnong

    Purpose: Hemorrhoidal disease impacts quality of life, with hemorrhoidectomy being the standard treatment for grades II–III hemorrhoids. Radiofrequency ablation (RFA) using the Rafaelo technique offers a less invasive alternative; however, comparative data remain limited. This study evaluated short-term outcomes following RFA versus conventional hemorrhoidectomy.Methods: A single-center retrospective cohort study was conducted at a medical university hospital in Thailand, involving patients who underwent either RFA or hemorrhoidectomy between January 2023 and September 2024. Propensity score matching was utilized to minimize selection bias. Primary outcomes were postoperative pain and opioid consumption.Results: After propensity score matching, 102 patients were analyzed (51 patients in each group). Baseline characteristics were well-balanced between the 2 groups. The RFA group had higher pain scores at 8 hours postoperatively (1 vs. 0, P=0.002) but lower scores at 20 hours (0 vs. 1, P<0.001). Opioid consumption was significantly lower in the RFA group (9.8% vs. 31.4%, P=0.007), with a reduced morphine-equivalent dose (0.7 mg vs. 3.5 mg, P=0.003). Additionally, the RFA group had a shorter operative time (20 minutes vs. 30 minutes, P<0.001) and less intraoperative blood loss (0 mL vs. 5 mL, P<0.001). Hospital stays and complication rates were comparable between groups.Conclusion: RFA resulted in improved postoperative pain control, reduced opioid use, shorter operative duration, and decreased blood loss compared to hemorrhoidectomy, with similar hospital stay durations and complication rates.